Action DMT SMALL PHARMA INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Small Pharma Inc.

Actions

DMT

CA8316641072

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Small Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023
Canadian Investment Regulatory Organization Trading Halt - DMT
Small Pharma Brief: Cybin Completed Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics
Cybin Inc. completed the acquisition of Small Pharma Inc. (TSXV : DMT).
Small Pharma Brief: Shareholders overwhelmingly voted in favour of Cybin's acquisition
Small Pharma Brief: Q2 FY24 Highlights Include Cash on hand as of August 31, 2023 of approximately C$7.7 million
Small Pharma Reports Fiscal Second Quarter 2024 Highlights
Small Pharma Reports Fiscal Second Quarter 2024 Highlights
Tranche Update on Small Pharma Inc.'s Equity Buyback Plan announced on August 18, 2022.
Small Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023
Cybin Inc. - Small Pharma Obtains Final Order Approving Arrangement
Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders
Disposition of Common Shares of Small Pharma Inc.
Disposition of Common Shares of Small Pharma Inc.
Cybin Inc. - Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
DMT-SSRI combination shows potential for depression
Small Pharma Notes Positive Top-line Data from SPL026-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
Small Pharma Brief: Reporting "Positive" Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
Small Pharma Inc. Reports Positive Top-line Data from SPL026 (DMT-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DMT
  4. Actualités Small Pharma Inc.
  5. Autres langues